Endothelial dysfunction in congestive heart failure: Effects of carvedilol

Heart Failure Reviews

Volumn 4, Issue 1, 1999, Pages 53-64

  Ferrari, R ^a   Agnoletti, L ^b   Ceconi, C ^b   Curello, S ^b   Nesta, F ^a   Manfredini, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b IRCCS   (Italy)

Author keywords

Apoptosis; Carvedilol; Endothelial dysfunction; Heart failure; Oxidative stress

Indexed keywords

CARVEDILOL;

ADRENERGIC RECEPTOR BLOCKING; ANTIOXIDANT ACTIVITY; APOPTOSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG MECHANISM; ENDOTHELIUM LESION; HUMAN; OXIDATIVE STRESS; REVIEW;

EID: 0032846883     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009855801777     Document Type: Review

References (74)

1. Packer M. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248-254.
2. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Co-operative North Scandinavian Enlapril Survival Study. New Engl J Med 1987;316:1429-1435.
3. Packer M, Bristow MR, Cohn JN, for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. New Engl J Med 1996;334:1349-1355.
4. Rales Study Report AT AHA, 1998.
5. Testa M, Yeh M, Lee P, Fanelli R, Loperfield F, Berman JW, Le Jemtel TH. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996;28:964-971.
6. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med 1990;323:236-241.
7. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479-1486.
8. Aukrust P, Veland Y, Muller F, Andreassen AK, Nordoy I, Aes H, Kiesshus J, Simonsen S, Froland SS, Gullestad L. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 1988;97:1136-1143.
9. Ferrari R. Tumor necrosis factor in CHF: A double facet cytokine. Cardiovasc Res 1998;37:554-559.
10. Ferrari R, Ceconi C, Curello S, Guarnieri C, Caldarera CM, Albertini A, Visioli O. Oxygen-mediated myocardial damage during ischaemia and reperfusion: Role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol 1985;17:937-945.
11. Australia/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to Ischaemic heart disease. Lancet 1997;349:375-380.
12. Feuerstein G, Yue TL, Xinliang MA, Ruffolo RR. Novel mechanisms in the treatment of heart failure: Inhibition of oxygen radicals and apoptosis by carvedilol. Prog Cardiovasc Dis 1998;41:17-24.
13. Ferrari R. The role of free radicals in ischaemic myocardium. Br J Clin Prac 1990;44:301-305.
14. Ferrari R, Curello S, Ceconi C, Cargnoni A, Condorelli E, Albertini A. Alterations of glutathione status during myocardial ischaemia and reperfusion. In: Singal PK, ed. Oxygen Radicals in the Pathophysiology of Heart Disease. Boston: Kluwer Academic Publishers, 1988:145-160.
15. Ferrari R, Ceconi C, Curello S, Cargnoni A, Agnoletti G, Boffa GM, Visioli O. Intracellular effects of myocardial ischaemia and reperfusion: Role of calcium and oxygen. Eur Heart J 1986;7:3-12.
16. Curello S, Ceconi C, Cargnoni A, Cornacchiari A, Ferrari R, Albertini A. Improved procedure for determining glutathione in plasma as an index of myocardial oxidative stress. Clin Chem 1987;33:1448-1449.
17. Ferrari R, Ceconi C, Curello S, Cargnoni A, Medici D. Oxygen-free radicals and reperfusion injury: The effect of ischaemia and reperfusion on the cellular ability to neutralise oxygen toxicity. J Mol Cell Cardiol 1986;18:67-69.
18. Dhalla AK, Singal PK. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol 1994;266: H1280-H1285.
19. Prasad K, Gupta JB, Kalra J, Lee P, Mantha SV, Bharadwaj B. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 1996;28:375-385.
20. Kirshenbaum LA, Singal PK. Antioxidant changes in heart hypertrophy: Significance during hypoxia-reoxygenation injury. Can J Physiol Pharmacol 1992;70:1330-1335.
21. Galinanes M, Ferrari R, Qui Y, Cargnoni A, Ezrin A, Hearse DJ. PEG-SOD and myocardial antioxidant status during ischaemia and reperfusion: Dose-response studies in isolated blood perfused rabbit heart. J Moll Cell Cardiol 1992;24: 1021-1030.
22. Wever RM, Luscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and two faces of endothelial nitric oxide synthase. Circulation 1988;97:108-112.
23. Tarr MT, Valenzeno DP. Modification of cardiac action potential by photosensitiser-generated reactive oxygen. J Mol Cell Cardiol 1989;21:539-543.
24. Pallandi RT, Perry MA, Campbell TJ. Proarrhythmic effects of an oxygen-derived free radical generating system on action potentials recorded from guinea pig ventricular myocardium: A possible cause of reperfusion-induced arrhythmias. Circ Res 1987;61:50-54.
25. Hearse DJ. Stunning: A radical re-view. Cardiovasc Drugs Ther 1991;5:853-876.
26. MacFarlane NG, Miller DJ. Depression of peak force without altering calcium sensitivity by the superoxide anion in chemically skinned cardiac muscle of rat. Circ Res 1992; 70:1217-24.
27. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 1997;80:393-399.
28. Singh N, Dhalla AK, Seneviratne C, Singal PK. Oxidative stress and heart failure. Mol Cell Biochem 1995;147:77-81.
29. Davies SW, Ranjadayalan K, Wickens DG, Dormandy TL, Umachandran V, Timmis AD. Free radical activity and left ventricular function after thrombolysis for acute infarction. Br Heart J 1993;69:114-120.
30. Roberts MJD, Young IS, Trouton TG, Trimble ER, Khan MM, Webb SW, Wilson CM, Patterson GC, Adgey AAJ. Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet 1990;336:143-145.
31. MacLellan WR, Schneiderm D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 1997;81:137-144
32. Nishiyama Y, Ikeda H, Haramaki N, Yoshida N, Imaizumi T. Oxidative stress is related to exercise intolerance in patients with heart failure. Am Heart J 1998;135:115-120.
33. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, Jeejeebhoy KN. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998;31:1352-1356.
34. Díaz-Vélez CR, García-Castiñeiras S, Mendoza-Ramos E, Hernández-López E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J 1996;131:146-152.
35. Comini L, Bachetti T, Agnoletti L, Gaia G, Curello S, Milanesi B, Volterrani M, Parrinello G, Ceconi C, Giordano A, Corti A, Ferrari R. Induction of functional inducible nitric oxide synthase in the monocytes of patients with congestive heart failure: Link with tumor necrosis factor-α. Eur Heart J; in press.
36. Weissmann G, Smolen JE, Korchak HM. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 1980;303:27-34.
37. 2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 1997;95:2492-2499.
38. Majno G, Joris I. Apoptosis, oncosis and necrosis: An overview of cell death. Am J Pathol 1995;146:3-15.
39. Hetts SW. To die or not to die. An overview of apoptosis and its role in disease. JAMA 1998;279:300-306.
40. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 1995;147:251-266.
41. Bjorkerud S, Bjorkarud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells) and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996; 149:367-380.
42. Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-I beta. Atheroscler Thromb Vasc Biol 1996;16:19-27.
43. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like protease: A mechanistic clue to the "response to injury" hypothesis. Circulation 1997;95:1760-1763.
44. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. Lab Invest 1991;64:5-15.
45. Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Koike M, Nomura M, Jie T, Ito K. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 1995;146:1325-1331.
46. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-323.
47. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert SR, Cigola E, Anversa P. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28:2005-2016.
48. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996;79:949-956.
49. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75:426-433.
50. MacLellan WR, Schneider MD. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 1997;81:137-144.
51. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, Anversa P. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 1995;73:771-787.
52. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest 1995;96:2247-2259.
53. Teiger E, Than VD, Richard L, Wisnewsky C, Tea BS, Gaboury L, Tremblay J, Schwartz K, Hamet P. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 1996;97:2891-2897.
54. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-1189.
55. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996;335:1190-1196.
56. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, Anversa P. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997;29: 859-870.
57. Thompson CB. Apoptosis in the patholgenesis and treatment of disease. Science 1995;267:1456-1462.
58. Wu CF, Bishopric NH, Pratt RE. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac cyocytes. J Biol Chem 1997;272:14860-14866.
59. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, Bredesen DE. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993;90:4533-4537.
60. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJE, Sabbadini RA. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996;98: 2854-2865.
61. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV. A novel domain within the 55b kd TNF receptor signals cell death. Cell 1993;74:845-853.
62. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171.
63. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-I, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspace-3. Cell 1997;90:405-413.
64. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and ATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-489.
65. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G. Mitochondrial control of nuclear apoptosis. J Exp Med 1996;183:1533-1544.
66. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995;1241:139-176.
67. Feuerstein G, Shusterman NH, Ruffolo RR Jr. Carvedilol update IV: Prevention of oxidative stress, cardiac remodeling and progression of congestive heart failure. Drugs Today 1997;33:453-473.
68. Aruoma OI. Scavenging of hypochlorous acid by carvedilol and elbselen in vitro. Gen Pharmacol 1997;28:269-272.
69. Aruoma OI. Peroxyl radical scavenging activity of the antihypertensive drug carvedilol. Toxicol Vitro 1996;10:625-629.
70. Kramer JH, Weglicki WB. A hydroxylated analog of the β-adrenoceptor antagonist, carvedilol affords exceptional antioxidant protection to post-ischemic rat hearts, Free Radic Biol Med 1996;21:813-825.
71. Christopher TA, Lopez B, Feuerstein GZ, et al. Effects of a hydroxylated metabolite of the β-adrenoreceptor antagonist, carvedilol on post-ischemic splanchnic tissue injury. Br J Pharmacol 1998;123:292-298.
72. Yue TL, Ma XL, Wang X, Romanic AM, Liu GL, Louden C, Gu JL, Kumar S, Poste G, Ruffolo RR, Feverstein GZ. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion induced cardiomyocyte apoptosis by carvedilol. Circ Res 1998;82:166-174.
73. Agnoletti L, Curello S, Bachetti T, Malacarne F, Gaia G, Comini L, Volterrani M, Bonetti P, Parrinello G, Cadei M, Grigolato PG, Ferrari R. Serum from patients with severe heart failure down-regulates eNOS and is pro-apoptotic: Role of the tumor necrosis factor-α. Circulation 1999; in Publications.
74. Rigoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring myocyte apoptosis to propidium iodide staining and flow cytometry. J Immunol Meth 1991;139:271-279.